glucagon has been researched along with nateglinide in 10 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (nateglinide) | Trials (nateglinide) | Recent Studies (post-2010) (nateglinide) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 441 | 112 | 120 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dan, K; Fujita, T; Hirose, H; Ito, K; Kanda, N; Kato, R; Maruyama, H; Saruta, T; Seto, Y | 1 |
| Dan, K; Hirose, H; Ito, K; Kato, R; Kido, K; Koyama, K; Maruyama, H; Saruta, T; Seto, Y | 1 |
| Akiyoshi, M; Fujitani, S; Ikenoue, T; Maki, T; Yada, T | 1 |
| Fuhlendorff, J; Ladrière, L; Leclercq-Meyer, V; Malaisse, WJ | 1 |
| Bokvist, K; Buschard, K; Gromada, J; Holst, JJ; Hoy, M; Thomsen, MK | 1 |
| de Souza, CJ; Dunning, BE; Lozito, R; Russo, P | 1 |
| Deacon, R; Dunning, BE; Foley, JE; Gutierrez, C; Paladini, S; Valentin, MA | 1 |
| Bauer, S; Brockmöller, J; Kirchheiner, J; Meineke, I; Meisel, C; Müller, G; Rohde, W; Roots, I | 1 |
| Groop, LC; Honkanen, EH; Isomaa, B; Sarelin, L; Tuomi, T | 1 |
| Breitschaft, A; Darstein, C; Golor, G; Hermosillo Reséndiz, K; Hu, K | 1 |
3 trial(s) available for glucagon and nateglinide
| Article | Year |
|---|---|
Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteers.
Topics: Adult; Alleles; Aryl Hydrocarbon Hydroxylases; Blood Glucose; Cyclohexanes; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Female; Genotype; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Metabolic Clearance Rate; Nateglinide; Phenylalanine; Polymorphism, Genetic; Prospective Studies | 2004 |
Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise Test; Female; Glucagon; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period | 2006 |
Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study.
Topics: Adamantane; Adolescent; Adult; Blood Glucose; Cyclohexanes; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Healthy Volunteers; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liraglutide; Male; Maximum Tolerated Dose; Metformin; Middle Aged; Nateglinide; Nitriles; Phenylalanine; Prognosis; Pyrrolidines; Somatostatin; Vildagliptin; Young Adult | 2014 |
7 other study(ies) available for glucagon and nateglinide
| Article | Year |
|---|---|
Effects of D-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and beta-cells: comparative study with glibenclamide.
Topics: Analysis of Variance; Animals; Cyclohexanes; Diazoxide; Drug Interactions; Glucagon; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Nateglinide; Perfusion; Phenylalanine; Rats; Rats, Wistar | 1995 |
Effects of N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166) on insulin and glucagon secretion in isolated perfused rat pancreas.
Topics: Animals; Cyclohexanes; Glucagon; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Nateglinide; Pancreas; Perfusion; Phenylalanine; Radioimmunoassay; Rats | 1994 |
Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channels; Cyclohexanes; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Nateglinide; Pancreas; Perfusion; Phenylalanine; Potassium Channels; Rats; Rats, Wistar; Somatostatin; Time Factors | 1996 |
Stimulation of insulin and somatostatin release by two meglitinide analogs.
Topics: Animals; Benzamides; Blood Glucose; Carbamates; Cyclohexanes; Female; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Nateglinide; Perfusion; Phenylalanine; Piperidines; Rats; Rats, Wistar; Somatostatin | 1997 |
Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells.
Topics: Animals; ATP-Binding Cassette Transporters; Calcium; Carbamates; Cyclohexanes; Eating; Electrophysiology; Exocytosis; Glucagon; Glucose; Hypoglycemic Agents; In Vitro Techniques; Islets of Langerhans; KATP Channels; Kinetics; Male; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Inbred Lew; Stimulation, Chemical | 1999 |
Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions.
Topics: Animals; Blood Glucose; Carbamates; Cyclohexanes; Food; Glipizide; Glucagon; Insulin; Insulin Secretion; Male; Nateglinide; Phenylalanine; Piperidines; Rats; Rats, Sprague-Dawley | 2001 |
Pharmacologic restoration of the early insulin response in pre-diabetic monkeys controls mealtime glucose excursions without peripheral hyperinsulinaemia.
Topics: Animals; Blood Glucose; Carbamates; Cyclohexanes; Fatty Acids, Nonesterified; Food; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Kinetics; Macaca fascicularis; Male; Nateglinide; Phenylalanine; Piperidines | 2003 |